Voyageur Pharmaceuticals Ltd.
VYYRF · OTC
11/30/2024 | 11/30/2023 | 11/30/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $6 | $10 | $9 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | -$0 | $6 | $10 | $9 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$1 | -$2 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$1 | -$2 | -$2 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.012 | -0.011 | -0.016 | -0.022 |
| % Growth | -15.9% | 34.4% | 24.9% | – |
| Operating Cash Flow | -$0 | -$1 | -$2 | -$2 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$1 | -$2 | -$2 |